Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.432ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.432ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.388EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.388EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.388ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.388ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.388EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.388EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.388ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.388ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.46EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-13011.1South Korea
B.46ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.46ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.46EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.46EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.139EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.139EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.139ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.139ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.139EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.139EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.139ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.139ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.508EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.508EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.508ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.508ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.508EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.508EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.508ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.508ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.94EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.94EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.94ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.94ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.94EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.94EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.94ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.94ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.463EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.463EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.463ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.463ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.463EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.463EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.463ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.463ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used